Thanks @Icebluedenim
As Van1 said, I'm sure the management team will find that of interest. I have been wondering how possible approval for other indications may effect MPL's orphan status for ALS/MND. I'm assuming it will not be a problem. There is a lot to take in, but my initial thoughts are that having multiple uses and balancing it all out is good problem to have.
Cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $70.91K | 420.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 104900 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 186536 | 2 |
View Market Depth
| Last trade - 15.35pm 14/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |